Clinical Trial Update: S9630, Medroxyprogesterone in Treating Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 study (S9630) evaluating medroxyprogesterone for treatment of breast cancer in women; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Endometrial Cancer | Phase 3 | Status: COMPLETED